Phase 2 study met its primary endpoint, demonstrating statistically significant improved overall survival with elraglusib plus gemcitabine/nab-paclitaxel versus chemotherapy aloneElraglusib...
-2026 is poised to be a data- and milestone-rich year across the portfolio- -CASGEVY® launch acceleration continues, supporting multi-billion-dollar potential-...
– First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries – Investigator-Initiated (IIT) funded pancreatic and...
– Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of...
Bitopertin was awarded the Commissioner’s National Priority Review Voucher (CNPV) and NDA is currently under FDA reviewUpdated data from the...
Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five additional...
Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds...
The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational...
New name reflects the Company’s strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilities Pre-IND...
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical...
Initial data from the Phase 1b FALCON trial expected in H2 2026, subject to participant enrollmentCHARLESTOWN, Mass., Jan. 12, 2026...
GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC)...
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued...
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record levelsHOUSTON, TX, Jan. 10, 2026...
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the topical skin tag solution now...
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving interest in transdermal metabolic support...
Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal disclosures, third-party COA availability, and...
NEW YORK CITY, NY / ACCESS Newswire / January 10, 2026 / The phrase best weight loss pills for 2026...
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement — What The Science Shows...
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access expands through telehealth — here...